Whedy Wang

1.7k total citations
20 papers, 1.1k citations indexed

About

Whedy Wang is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Whedy Wang has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in Whedy Wang's work include Cardiac Imaging and Diagnostics (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Whedy Wang is often cited by papers focused on Cardiac Imaging and Diagnostics (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Whedy Wang collaborates with scholars based in United States, Argentina and United Kingdom. Whedy Wang's co-authors include Luiz Belardinelli, John O. Parker, Carl J. Pepine, J Kuch, Sandra Skettino, Bernard Chaitman, David Hébert, Peter C. Hanley, Jeanenne J. Nelson and Andrew A. Wolff and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Clinical Infectious Diseases.

In The Last Decade

Whedy Wang

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Whedy Wang United States	10	651	416	256	143	104	20	1.1k
Edward Y. Sako United States	21	331 0.5×	249 0.6×	669 2.6×	216 1.5×	161 1.5×	51	1.4k
Ralf Dikow Germany	20	243 0.4×	107 0.3×	167 0.7×	81 0.6×	86 0.8×	43	1.0k
Luciano Babuin Italy	11	848 1.3×	329 0.8×	261 1.0×	230 1.6×	155 1.5×	19	1.3k
E. Mueller Switzerland	17	192 0.3×	91 0.2×	193 0.8×	71 0.5×	118 1.1×	40	881
Silvia Moreira Ayub‐Ferreira Brazil	16	574 0.9×	34 0.1×	111 0.4×	113 0.8×	205 2.0×	59	876
Nilesh J. Samani United Kingdom	10	322 0.5×	70 0.2×	82 0.3×	107 0.7×	55 0.5×	11	772
Nancy Morrison Canada	15	144 0.2×	87 0.2×	152 0.6×	36 0.3×	37 0.4×	19	1.2k
Abdallah Al‐Mohammad United Kingdom	25	1.2k 1.8×	682 1.6×	316 1.2×	100 0.7×	154 1.5×	76	1.8k
Fabiana G. Marcondes‐Braga Brazil	13	384 0.6×	25 0.1×	186 0.7×	69 0.5×	140 1.3×	57	753
Alon Marmor Israel	18	1.2k 1.9×	392 0.9×	430 1.7×	97 0.7×	310 3.0×	76	1.8k

Countries citing papers authored by Whedy Wang

Since Specialization

Citations

This map shows the geographic impact of Whedy Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Whedy Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Whedy Wang more than expected).

Fields of papers citing papers by Whedy Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Whedy Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Whedy Wang. The network helps show where Whedy Wang may publish in the future.

Co-authorship network of co-authors of Whedy Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Whedy Wang. A scholar is included among the top collaborators of Whedy Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Whedy Wang. Whedy Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Guoqiao, Gary Cutter, Neil P. Oxtoby, et al.. (2024). Statistical considerations when estimating time‐saving treatment effects in Alzheimer's disease clinical trials. Alzheimer s & Dementia. 20(8). 5421–5433. 9 indexed citations

Wang, Guoqiao, Whedy Wang, Lon S. Schneider, et al.. (2024). Novel non‐linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methods. Statistics in Medicine. 43(15). 2987–3004. 1 indexed citations

Kaufmann, Horacio, Ross G. Vickery, Whedy Wang, et al.. (2021). Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial. Clinical Autonomic Research. 31(6). 699–711. 16 indexed citations

Raj, Satish R., Lucy Norcliffe‐Kaufmann, Whedy Wang, Brett Haumann, & Ross G. Vickery. (2020). HEMODYNAMIC EFFECTS AND CARDIOVASCULAR SAFETY OF ONCE-DAILY ORAL AMPRELOXETINE (TD-9855), A NOREPINEPHRINE REUPTAKE INHIBITOR, IN HEALTHY ADULTS AND SUBJECTS WITH SYMPTOMATIC NEUROGENIC ORTHOSTATIC HYPOTENSION. Journal of the American College of Cardiology. 75(11). 333–333. 1 indexed citations

Wilson, Samuel E., et al.. (2017). Telavancin in the Treatment of Concurrent Staphylococcus aureus Bacteremia: A Retrospective Analysis of ATLAS and ATTAIN Studies. Infectious Diseases and Therapy. 6(3). 413–422. 14 indexed citations

Smart, Jennifer I., G. Ralph Corey, Martín E. Stryjewski, Whedy Wang, & Steven L. Barriere. (2016). Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical Isolates. Infectious Diseases and Therapy. 5(4). 535–544. 4 indexed citations

Smart, Jennifer I., G. Ralph Corey, Martín E. Stryjewski, Whedy Wang, & Steven L. Barriere. (2016). Assessment of telavancin minimal inhibitory concentrations by revised broth microdilution method in phase 3 complicated skin and skin-structure infection clinical trial isolates. Diagnostic Microbiology and Infectious Disease. 87(3). 268–271. 4 indexed citations

Lacy, Melinda K., Martín E. Stryjewski, Whedy Wang, et al.. (2015). Telavancin Hospital-Acquired Pneumonia Trials: Impact of Gram-Negative Infections and Inadequate Gram-Negative Coverage on Clinical Efficacy and All-Cause Mortality. Clinical Infectious Diseases. 61(suppl 2). S87–S93. 19 indexed citations

Barriere, Steven L., et al.. (2015). Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA Guidance. Antimicrobial Agents and Chemotherapy. 59(10). 6170–6174. 6 indexed citations

10.

Karwatowska‐Prokopczuk, Ewa, Whedy Wang, Mei Cheng, et al.. (2012). The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine. EP Europace. 15(3). 429–436. 32 indexed citations

11.

Scirica, Benjamin M., Eugene Braunwald, Luiz Belardinelli, et al.. (2010). Relationship Between Nonsustained Ventricular Tachycardia After Non–ST-Elevation Acute Coronary Syndrome and Sudden Cardiac Death. Circulation. 122(5). 455–462. 76 indexed citations

12.

Hage, Fadi G., Jaekyeong Heo, Billy Franks, et al.. (2009). Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus. American Heart Journal. 157(4). 771–776. 46 indexed citations

13.

Iskandrian, Ami E., Timothy M. Bateman, Luiz Belardinelli, et al.. (2007). Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial. Journal of Nuclear Cardiology. 14(5). 645–658. 238 indexed citations

14.

Eisen, Howard J., Jon Kobashigawa, Anne Keogh, et al.. (2005). Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant Recipients. The Journal of Heart and Lung Transplantation. 24(5). 517–525. 185 indexed citations

15.

Chaitman, Bernard, Sandra Skettino, John O. Parker, et al.. (2004). Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. Journal of the American College of Cardiology. 43(8). 1375–1382. 410 indexed citations

16.

Chaitman, Bernard, Sandra Skettino, Carl J. Pepine, et al.. (2003). Ranolazine increases exercise performance and decreases hemoglobin A1C in angina patients with diabetes. Journal of the American College of Cardiology. 41(6). 378–378. 5 indexed citations

17.

Wang, Whedy, et al.. (1996). Use of lattice square designs in bioassays. Journal of Biopharmaceutical Statistics. 6(2). 185–199. 3 indexed citations

18.

Wang, Whedy. (1994). Analysis of a lattice square design and its use in bioassays.. Deep Blue (University of Michigan). 1 indexed citations

19.

Wan, Jim Y., Whedy Wang, & Judith Bromberg. (1994). A SAS macro for residual deviance of ordinal regression analysis. Computer Methods and Programs in Biomedicine. 45(4). 307–310. 2 indexed citations

20.

Kennedy, Cheryl A., Joan Skurnick, Jim Y. Wan, et al.. (1993). Psychological distress, drug and alcohol use as correlates of condom use in HIV-serodiscordant heterosexual couples. AIDS. 7(11). 1493–1500. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact